Expertise in
10
conditions

Heinz Gisslinger

Vienna, AT 
Expertise in
10
conditions
Vienna, AT 

Overview

Heinz Gisslinger practices practicing medicine in Vienna, Austria.

Mr. Gisslinger is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Splenomegaly, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 132 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Vienna, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)
A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)
Enrollment Status: Completed
Publish Date: November 18, 2025
Intervention Type: Drug
Study Phase: Phase 2
Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Enrollment Status: Completed
Publish Date: December 13, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

132 Total Publications

A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia.
A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia.
Journal: American journal of hematology
Published: July 03, 2025

Frequently Asked Questions about Heinz Gisslinger

Is Heinz Gisslinger a top-rated expert for Polycythemia Vera?

MediFind is an objective health platform that identifies experts based on real-world data. Heinz Gisslinger is classified as an Elite expert for Polycythemia Vera, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Heinz Gisslinger participate in research or clinical trials?

Yes. Heinz Gisslinger has published 132 articles and abstracts on conditions like Polycythemia Vera. You can view a list of Heinz Gisslinger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gisslinger's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile